Detection and reporting β-lactam resistance phenotypes in Escherichia coli and Klebsiella pneumoniae: a multicenter proficiency study in Spain

Diagnostic Microbiology and Infectious Disease

Volumn 62, Issue 3, 2008, Pages 317-325

  Conejo, M Carmen ^a   Mata, C ^b,c   Navarro, F ^b,c   Pascual, A ^a,d  

^a UNIVERSITY OF SEVILLE   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

Author keywords

Lactamase; AST; ESBL; Quality control

Indexed keywords

AZTREONAM; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; CEPHALOSPORIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM DETECTION; BACTERIUM ISOLATE; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; MEASUREMENT ERROR; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SPAIN;

BETA-LACTAM RESISTANCE; BETA-LACTAMASES; ESCHERICHIA COLI; HUMANS; KLEBSIELLA PNEUMONIAE; LABORATORIES; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; QUALITY CONTROL; SPAIN;

EID: 53949102018     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2008.06.010     Document Type: Article

References (14)

1. Alvarez M., Tran J.H., Chow N., and Jacoby G.A. Epidemiology of conjugative plasmid-mediated AmpC β-lactamases in the United States. Antimicrob. Agents Chemother. 48 (2004) 533-537
2. Baquero F., Martínez Beltrán J., and Cantón R. MENSURA break-points. Spanish criteria for determination of susceptibility to antibiotics. Rev. Esp. Quimioter. 10 (1997) 303-313
3. Cantón R., Loza E., Conejo M.C., Baquero F., and Martínez-Martínez L. Quality control for β-lactam susceptibility testing with a well-defined collection of Enterobacteriaceae and Pseudomonas aeruginosa strains in Spain. J. Clin. Microbiol. 41 (2003) 1912-1918
4. Cantón R., Valverde A., Novais A., Baquero F., and Coque T. Evolution and current situation of ESBL. Enferm. Infecc. Microbiol. Clin. 25 Suppl 2 (2007) S2-S10
5. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, document M100-S17. Seventeenth informational supplement (2007), Clinical and Laboratory Standards Institute, Wayne, PA
6. Hernández J.R., Martínez-Martínez L., Cantón R., Coque T.M., and Pascual A. Nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases in Spain. Antimicrob. Agents Chemother. 49 (2005) 2122-2125
7. Livermore D.M., Hope R., Mushtaq S., and Warner M. Orthodox and unorthodox clavulanate combinations against extended-spectrum β-lactamase producers. Clin. Microbiol. Infect. 14 Suppl 1 (2008) 189-193
8. Luzzaro F., Gesu G., Endimiani A., Ortisi G., Malandrin S., Pagani L., and Rossolini G.M. Performance in detection and reporting β-lactam resistance phenotypes in Enterobacteriaceae: a nationwide proficiency study in Italian laboratories. Diagn. Microbiol. Infect. Dis. 55 (2006) 311-318
9. Mirelis B., Rivera A., Miró E., Mesa R.J., Navarro F., and Coll P. A simple phenotypic method for differentiation between acquired chromosomal AmpC β-lactamases in Escherichia coli. Enferm. Infecc. Microbiol. Clin. 24 (2006) 370-372
10. Miró E., Mirelis B., Navarro F., Rivera A., Mesa R.J., Roig M.C., Gómez L., and Coll P. Surveillance of extended-spectrum β-lactamases from clinical samples and faecal carriers in Barcelona, Spain. J. Antimicrob. Chemother. 56 (2005) 1152-1155
11. Paterson D.L. Resistance in gram-negative bacteria: Enterobacteriaceae. Am. J. Med. 119 Suppl 6A (2006) S20-S28
12. Paterson D.L., Ko W.C., Von Gottberg A., Mohapatra S., Casellas J.M., Goossens H., Mulazimoglu L., Trenholme G., Klugman K.P., Bonomo R.A., Rice L.B., Wagener M.M., McCormack J.G., and Yu V.L. Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum β-lactamases. Clin. Infect. Dis. 39 (2004) 31-39
13. Peterson L.R. Antibiotic policy and prescribing strategies for therapy of extended spectrum β-lactamase-producing Enterobacteriaceae: the role of piperacillin-tazobactam. Clin. Microbiol. Infect. 14 Suppl 1 (2008) 181-184
14. Philippon A., Arlet G., and Jacoby G.A. Plasmid-determined AmpC-type β-lactamases. Antimicrob. Agents Chemother. 46 (2002) 1-11